SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
FRA:SHL - Deutsche Boerse Ag - DE000SHL1006 - Common Stock - Currency: EUR
SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
In the past 5 years SHL has always been profitable.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.22%, SHL is doing good in the industry, outperforming 68.63% of the companies in the same industry.
With an excellent Return On Equity value of 10.67%, SHL belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.39%, SHL is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 8.18%.
The last Return On Invested Capital (6.39%) for SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.22% | ||
| ROE | 10.67% | ||
| ROIC | 6.39% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
With a decent Profit Margin value of 8.68%, SHL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of SHL has declined.
The Operating Margin of SHL (12.57%) is better than 64.71% of its industry peers.
In the last couple of years the Operating Margin of SHL has declined.
With a Gross Margin value of 37.87%, SHL is not doing good in the industry: 78.43% of the companies in the same industry are doing better.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.57% | ||
| PM (TTM) | 8.68% | ||
| GM | 37.87% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SHL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
SHL has an Altman-Z score of 2.14. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SHL (2.14) is comparable to the rest of the industry.
SHL has a debt to FCF ratio of 7.62. This is a slightly negative value and a sign of low solvency as SHL would need 7.62 years to pay back of all of its debts.
The Debt to FCF ratio of SHL (7.62) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.74 indicates that SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.74) is worse than 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 7.62 | ||
| Altman-Z | 2.14 |
ROIC/WACC1.11
WACC5.74%
2.3 Liquidity
A Current Ratio of 1.25 indicates that SHL should not have too much problems paying its short term obligations.
SHL's Current ratio of 1.25 is on the low side compared to the rest of the industry. SHL is outperformed by 66.67% of its industry peers.
SHL has a Quick Ratio of 1.25. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL's Quick ratio of 0.89 is on the low side compared to the rest of the industry. SHL is outperformed by 62.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
SHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.95%, which is quite good.
Measured over the past 5 years, SHL shows a small growth in Earnings Per Share. The EPS has been growing by 7.27% on average per year.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 3.15% in the last year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)10.95%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%15.52%
Revenue 1Y (TTM)3.15%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.51%
3.2 Future
The Earnings Per Share is expected to grow by 11.45% on average over the next years. This is quite good.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 6.54% on average per year.
EPS Next Y14.31%
EPS Next 2Y13.81%
EPS Next 3Y11.7%
EPS Next 5Y11.45%
Revenue Next Year5.4%
Revenue Next 2Y5.81%
Revenue Next 3Y6.21%
Revenue Next 5Y6.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.37, which indicates a rather expensive current valuation of SHL.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 76.47% of the companies listed in the same industry.
SHL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.19.
A Price/Forward Earnings ratio of 21.32 indicates a rather expensive valuation of SHL.
60.78% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.37. SHL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.37 | ||
| Fwd PE | 21.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued a bit cheaper than the industry average as 74.51% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.78 | ||
| EV/EBITDA | 18.34 |
4.3 Compensation for Growth
SHL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.7
PEG (5Y)3.35
EPS Next 2Y13.81%
EPS Next 3Y11.7%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 1.86%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.50, SHL pays a bit more dividend than its industry peers.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.86% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years2
Div Non Decr Years5
5.3 Sustainability
54.74% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP54.74%
EPS Next 2Y13.81%
EPS Next 3Y11.7%
SIEMENS HEALTHINEERS AG
FRA:SHL (1/23/2025, 5:35:30 PM)
54.34
+0.38 (+0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap61.30B
Analysts82.96
Price Target60.05 (10.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.86% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP54.74%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.77%
Min EPS beat(2)-0.13%
Max EPS beat(2)3.67%
EPS beat(4)3
Avg EPS beat(4)4.47%
Min EPS beat(4)-0.13%
Max EPS beat(4)9.31%
EPS beat(8)5
Avg EPS beat(8)2.11%
EPS beat(12)8
Avg EPS beat(12)2.54%
EPS beat(16)10
Avg EPS beat(16)29.15%
Revenue beat(2)0
Avg Revenue beat(2)-1.92%
Min Revenue beat(2)-3.02%
Max Revenue beat(2)-0.81%
Revenue beat(4)0
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)-0.81%
Revenue beat(8)1
Avg Revenue beat(8)-1.06%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)8
Avg Revenue beat(16)0.86%
PT rev (1m)-0.55%
PT rev (3m)0.24%
EPS NQ rev (1m)-1.9%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.15%
Revenue NQ rev (1m)4.26%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-1.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.37 | ||
| Fwd PE | 21.32 | ||
| P/S | 2.74 | ||
| P/FCF | 28.78 | ||
| P/OCF | 21.69 | ||
| P/B | 3.37 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.34 |
EPS(TTM)2.23
EY4.1%
EPS(NY)2.55
Fwd EY4.69%
FCF(TTM)1.89
FCFY3.47%
OCF(TTM)2.51
OCFY4.61%
SpS19.83
BVpS16.13
TBVpS-5.78
PEG (NY)1.7
PEG (5Y)3.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.22% | ||
| ROE | 10.67% | ||
| ROCE | 8.15% | ||
| ROIC | 6.39% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 32.17% | ||
| OM | 12.57% | ||
| PM (TTM) | 8.68% | ||
| GM | 37.87% | ||
| FCFM | 9.52% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 7.62 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 56.91% | ||
| Cap/Sales | 3.11% | ||
| Interest Coverage | 7.87 | ||
| Cash Conversion | 70.07% | ||
| Profit Quality | 109.68% | ||
| Current Ratio | 1.25 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.14 |
F-Score8
WACC5.74%
ROIC/WACC1.11
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)10.95%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%15.52%
EPS Next Y14.31%
EPS Next 2Y13.81%
EPS Next 3Y11.7%
EPS Next 5Y11.45%
Revenue 1Y (TTM)3.15%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.51%
Revenue Next Year5.4%
Revenue Next 2Y5.81%
Revenue Next 3Y6.21%
Revenue Next 5Y6.54%
EBIT growth 1Y31.8%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year56.05%
EBIT Next 3Y24.13%
EBIT Next 5Y18.01%
FCF growth 1Y66.28%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y33.36%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%